Get the Stockscreener App
0.3276
4.00%
0.0126
After Hours:
.32
-0.0076
-2.32%
Biomerica Inc stock is traded at $0.3276, with a volume of 13,082.
It is up +4.00% in the last 24 hours and down -25.55% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$0.315
Open:
$0.315
24h Volume:
13,082
Relative Volume:
0.04
Market Cap:
$5.51M
Revenue:
$5.41M
Net Income/Loss:
$-6.35M
P/E Ratio:
-0.6552
EPS:
-0.5
Net Cash Flow:
$-5.39M
1W Performance:
+9.20%
1M Performance:
-25.55%
6M Performance:
-60.62%
1Y Performance:
-61.92%
1-Day Range:
$0.3071
$0.344
1-Week Range:
$0.292
$0.37
52-Week Range:
$0.2415
$2.13
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-20 | Initiated | Colliers Securities | Buy |
| Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Increases By 582.1% - Defense World
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Bokf Na Acquires Shares of 375 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Cut to $115.00 by Analysts at Bank of America - Defense World
BioMarin price target lowered to $115 from $130 at BofA - TipRanks
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Acadian Asset Management LLC - Defense World
BioE3 Policy implementation and potential in Futuristic growth of J&K - Daily Excelsior
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher - MSN
Views of Wall Street’s Leading Experts on Biomerica Inc. - SETE News
Biomerica Inc. [BMRA] Stock trading around $0.38 per share: What’s Next? - The DBT News
BMRA’s 2023 Market Dance: Down -70.48% – Time to Invest? - The InvestChronicle
Saudi Arabia approves Biomerica's prostate cancer test - Investing.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica’s At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - ForexTV.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - StockTitan
Financial Metrics Exploration: Understanding Biomerica Inc. (BMRA) Through Ratios - The Dwinnex
Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023) - Yahoo Finance
Biomerica Reports Fiscal 2024 Year End Results - ForexTV.com
Biomerica Reports Fiscal 2024 Year End Results - StockTitan
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average of $0.66 - Defense World
Biomerica stock plunges to 52-week low of $0.28 - Investing.com India
Biomerica stock plunges to 52-week low of $0.28 - Investing.com
Biomerica (NASDAQ:BMRA) Share Price Crosses Below 200 Day Moving Average of $0.76 - Defense World
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 54.4% in June - Defense World
BMRABiomerica, Inc. Latest Stock News & Market Updates - StockTitan
Biomerica (NASDAQ:BMRA) Stock Passes Below 200-Day Moving Average of $0.83 - Defense World
Is Biomerica Inc. (BMRA) a good investment opportunity? – US Post News - US Post News
Financial Analysis: Biomerica Inc. (BMRA)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - StockTitan
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS ... - Afternoon Headlines
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average of $0.86 - Defense World
Biomerica Chairman Jack Kenny steps down By Investing.com - Investing.com Australia
Biomerica Chairman Jack Kenny steps down By Investing.com - Investing.com South Africa
Biomerica Chairman Jack Kenny steps down By Investing.com - Investing.com
Biomerica Chairman Jack Kenny Resigns Suddenly - TipRanks
Biomerica Chairman Jack Kenny steps down By Investing.com - Investing.com UK
Biomerica Chairman Jack Kenny steps down - Investing.com
Helicobacter Pylori Diagnostics Market Gaining Momentum with Positive External Factors - Taiwan News
Biomerica, Inc.'s (NASDAQ:BMRA) Path To Profitability - Yahoo New Zealand News
Biomerica Inc. (BMRA)’s financial ratios: A comprehensive overview - The Dwinnex
All Board Members of Biomerica to Purchase Biomerica Common Stock Shares in the Open Market - Yahoo Movies UK
Russell Investments Group Ltd. Purchases 26288 Shares of Biomerica, Inc. (NASDAQ:BMRA) - Defense World
Macy's, Inc. (NYSE:M) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
What Did Biomerica's (NASDAQ:BMRA) CEO Take Home Last Year? - Yahoo Canada Shine On
Biomerica Announces Year End ResultsYahoo Sport - Yahoo Eurosport UK
Holdings of Biomerica Inc. (BMRA) are aligned with the stars – Sete News - SETE News
Biomerica Inc.: Does BMRA Stock Make Heads Or Tails? – Stocks Register - Stocks Register
Biomerica pilots new IBS dietary management program - Investing.com India
Biomerica pilots new IBS dietary management program By Investing.com - Investing.com
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 - GlobeNewswire Inc.
Biomerica Announces Second Quarter Financial Results - Yahoo News UK
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):